학술논문
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
Document Type
Article
Author
Source
In Pulmonary Pharmacology & Therapeutics April 2015 31:36-41
Subject
Language
ISSN
1094-5539